These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12281066)

  • 1. [Injectable contraceptive: nuclear effects after use].
    Figueira TD
    J Bras Ginecol; 1986 Aug; 96(8):391-7. PubMed ID: 12281066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preclinical research and development of norethisterone].
    Mcguire JL; Hahn DW; Philipps A
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):437-44. PubMed ID: 12280212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical investigation of medroxyprogesterone acetate and estradiol cypionate in contraceptive injection administered monthly].
    Rustrian A; Luyando H
    Ticitl; 1975 Sep; 14(3):98-100. PubMed ID: 12336077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of intrauterine contraceptive devices on the endometrium].
    Sheppard BL; Bonnar J
    Contracept Fertil Sex (Paris); 1987 Nov; 15(11):1015-24. PubMed ID: 12341565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased retention of intrauterine contraceptive devices medicated with indomethacin and medroxyprogesterone acetate.
    Von Dadelszen P; Hurst PR; Peplow PV
    Proc Univ Otago Med Sch; 1981 Oct; 59(3):101-3. PubMed ID: 12264137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of medroxyprogesterone: a long-acting injectable female contraceptive agent.
    Ahmad G; Rasul A
    Pak J Med Res; 1970 Jan; 9(1):46-9. PubMed ID: 12255593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of endometrial maturation under the influence of an oestrogen-progestin combination containing 30 mcg of EE and 150 mcg of desogestrel: the value of biopsy of the endometrium in assessing the efficacy of an oestrogen-progestin combination].
    Nahmanovici C; De Brux J; Audebert A; Berdah J; Mayer M; Bouchard P
    Fertil Contracept Sex; 1988 Apr; 16(4):305-8. PubMed ID: 12342377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructure of endometrium of postmenopausal patients on two modes of hormonal therapy: estrone sulfate with or without MPA.
    Wilborn WH; Flowers Ce ; Hyde BM
    Contracept Deliv Syst; 1983 Jan; 4(1):71-85. PubMed ID: 12264720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Estrogen and progesterone receptors in uterine cervix].
    Brentani MM; Lopes MT; Pereyra EG; Pacheco MM; Oshima CT; Widman A; De Almeida PC
    J Bras Ginecol; 1985; 95(9):411-5. PubMed ID: 12267713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracervical device may be effective hormonal contraceptive.
    Contracept Technol Update; 1988 Jul; 9(7):81-3. PubMed ID: 12281577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiprogestogens: from abortion to contraception.
    Prog Hum Reprod Res; 1992; (22):6-7. PubMed ID: 12286013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progestogen contraception using chlormadinone acetate in women presenting high vascular risk. (A gynecoendocrine, metabolic and vascular study).
    Pelissier C; Basdevant A; Conard J; Egloff M; Husson T; Guyenne TT
    Contracept Fertil Sex (Paris); 1987 Jan; 15(1):45-54. PubMed ID: 12315161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relation of the structure of progestational steroids to nucleolar differentiation in human endometrium.
    Kohorn EI; Rice SI; Hemperly S; Gordon M
    J Clin Endocrinol; 1972; 34():257-64. PubMed ID: 12256658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fertility regulation technology: status and prospects.
    Segal SJ; Nordberg OS
    Popul Bull; 1977 Mar; 31(6):1-25. PubMed ID: 12335682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian morphological changes with injectable contraceptives and their relation to cycle control.
    Yassin S; El-mahgoub S; Ammar R; Karim M
    Ain Shams Med J; 1971 Jul; 22(4):497-501. PubMed ID: 12256861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal LHRH agonist (Buserelin) after ovulation: a post-coital contraceptive approach.
    Lemay A; Faure N; Labrie F; Fazekas AT
    Contracept Deliv Syst; 1983 Apr; 4(2):107-25. PubMed ID: 12338631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endometrial effects of norethindrone in daily uninterrupted microdoses].
    Salum R; Reis Lopes E; Chapadeiro E
    J Bras Ginecol; 1971; 71(2):99-104. PubMed ID: 12256722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose progestagens as contraceptive agents.
    Elstein M
    IPPF Med Bull; 1970; 4(1):2-4. PubMed ID: 12255089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of lyndiol and its components on the rat uterine histology and most cell content.
    Ghazal A; Aziz A; Daabees T; Loutfi I
    J Drug Res; 1974 Dec; 6(3):169-82. PubMed ID: 12333668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pill and the breast.
    Drife JO
    IPPF Med Bull; 1984 Dec; 18(6):1-2. PubMed ID: 12313402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.